(Q63840804)
Statements
ENGYNE (English)
0 references
A 12-month, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Fingolimod in the Treatment of Relapsing-remitting Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta (English)
0 references
June 2013
0 references
June 2014
0 references
0
0 references
18 year
0 references
65 year
0 references